Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000796569 | SCV001370821 | likely pathogenic | Phenylketonuria | 2020-04-10 | reviewed by expert panel | curation | The c.1304A>T (p.Asp435Val) variant in PAH has been reported in a Uygur patient with moderate PKU (BH4 deficiency ruled out) (PP4_Moderate; PMID: 31355225). This variant was detected with p.Ala434Asp (Likely pathogenic in ClinVar) (PM3; PMID: 31355225). The variant is absent from population databases (PM2). Computational evidence is conflicting. In summary, this variant meets criteria to be classified as likely pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PM2, PM3, PP4_Moderate. |
Labcorp Genetics |
RCV000796569 | SCV000936088 | likely pathogenic | Phenylketonuria | 2021-12-02 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PAH protein function. ClinVar contains an entry for this variant (Variation ID: 625291). This missense change has been observed in individual(s) with clinical features of PAH-related conditions (PMID: 31332730, 31355225, 32668217). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces aspartic acid, which is acidic and polar, with valine, which is neutral and non-polar, at codon 435 of the PAH protein (p.Asp435Val). |
Center for Molecular Medicine, |
RCV000796569 | SCV000893132 | pathogenic | Phenylketonuria | 2019-03-08 | no assertion criteria provided | clinical testing |